Volume : 12, Issue : 10, October – 2025
Title:
FORMULATION DEVELOPMENT OF CHITOSAN GELS ENRICHED WITH VANCOMYCIN HCL SOLID LIPID NANOPARTICLES
Authors :
Elipe Dinesh*, I. Nagaraju, Dr. Vijay Kumar Gampa
Abstract :
The present study was aimed at the formulation and development of chitosan-based gels incorporated with Vancomycin HCl-loaded solid lipid nanoparticles (SLNs) for enhanced topical delivery. Vancomycin HCl, a potent glycopeptide antibiotic, was encapsulated into SLNs to improve its stability and controlled release profile. These SLNs were subsequently integrated into a chitosan gel matrix to facilitate effective topical application. The formulations were evaluated for particle size, zeta potential, entrapment efficiency, pH, viscosity, spreadability, drug content, and in vitro drug release. The optimized formulation exhibited desirable physicochemical properties, high drug encapsulation, and sustained drug release, making it suitable for localized treatment of bacterial infections. The study concludes that chitosan gels enriched with Vancomycin HCl SLNs provide a promising and effective strategy for the topical delivery of antibiotics with improved therapeutic outcomes and patient compliance.
Keywords: Vancomycin HCl, chitosan-based gels
Cite This Article:
Please cite this article in press Elipe Dinesh et al., Formulation Development Of Chitosan Gels Enriched With Vancomycin Hcl Solid Lipid Nanoparticles, Indo Am. J. P. Sci, 2025; 12(10).
REFERENCES:
1. Mader, Kand, Mehnert W. Solid lipid nanoparticles production, characterization and applications. Adv Drug Del Rev.;47165-196, 2001.
2. Muller RH and Freitas C. Correlation between long-term stability of solid lipid nanoparticles(SLN) and crystallinity of the lipidphase. Eur J Pharma Biopharm;47:125-132, 1999.
3. Muhlen ZA, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery drug release and release mechanism. Eur J Pharm Biopharm.;45(2):149-155, Mar 1998.
4. Bolakatti GS, Maddi VS, Mamledesai SN, Ronad PM, Palkar MB and SwamyS. Synthesis and evaluation of Anti-inflammatory and Analgesic activities of a novel series of coumarin Mannich bases.Arz-For (Drug Research).;58(10):515-520, 2008.
5. Goodman and Gilman. Analgesic-anti pyretic and anti-inflammatory agents; pharmaco therapy of gout. Brunton LL, LazoJS, ParkerKL, editors. ThePharmacological Basis of Therapeautics. 11th ed. NewYork. McGraw-Hill.. 671-674, 2006 .(Book)
6. Balfour JA, Fitton A, Barradell LB. Lornoxicam: A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions. Drugs ,51(4)639-657, 1996.
7. Malafaya PB, Silva GA, Baran ET, Reis RL. Drug delivery therapies General trends and its importance in bone tissue engineering applications.CurOp Solid State and Mat Sci.;6:283-295, 2000.
8. Wong HL, Rauth AM, Bendayan R, Wu XY. In Vivo Evaluation of a New Polymer-Lipid Hybrid Nanoparticle (PLN) Formulation of Doxorubicin in a Murine Solid Tumor Model. Eur J Pharm Bio pharm.,10(022):1-28, 2006.
9. Claudia B, Otto C, Roberta C, Ludovica G , Antonella M and Maria RG. Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles. Int J Pharm, 175:185-193(1998)
10. Muller RH , Wissing SA and Kayser. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Del Rev, 56:1257-1272(2004)
11. WolfgangM, KarstenM. Solid lipid nanoparticles :Production, characterization and applications. Adv Drug Del Rev, 47:165-196(2001)
12. Rainer HM, Karsten M, Sven G. Solid lipid nano particles (SLN)for controlled drug delivery-a review of the state of the art. Eur J Pharm Bio pharm 50:161-177(2000)
13. Pignatello R, Du YZ, Yuan H, YeYQ, Zeng S. Preparation and characterization of stearic acid nano structure dlipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B Biointer faces,45:167–173(2006).
14. Puglia C, Samad A, Ali A, Aqil M, Sharma M, Mishra AK. Gelrite-based in-vitro gelation ophthalmic drug delivery system of gatifloxacin. J Disp Sci Tech, 29:89–96(2010).
15. Casadei M.A, Solid lipid nano particles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles : preparation and characterization. Int J Pharm, 340:153–162(2010).
16. Kockbek P, Mehnert W, Lucks JS, Schwarz C, zur-Muhlen A, Weyhers H, Freitas C, Ruhl D. Solid lipid nanoparticles an alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm,41:62–69(2010).
17. Cavalli R, Caputo O, Carlotti ME, Trotta M, Scarnecchia C, Gasco MR.. Sterilization and freeze – drying of drug-free and drug-loaded solid lipid nanoparticles. Int J Pharm, 148:47–54. (1997).
18. Dingler A, Gohla S. Production of solid lipid nano particles (SLN): scaling up feasibilities. J Micro encapsul,19:11–16, (2002).
19. Freitas C, Müller RH. Correlation between long-term stability of solid lipid nano particles (SLN) and crystallinity of the lipid phase. Eur J Pharm Biopharm, 47:125–132, (1999).